Cointime

Download App
iOS & Android

Terns Pharmaceuticals

company
Funding Round
Post-IPO Equity
Money Raised
$ 86.30M
Propotion
-
Post Valuation
-

Current Round Investors

Investor Name Invest Money Lead Investor Propotion

Historical Financing

Announced Date Round Money Raised Investors
Aug 12, 2022 Post-IPO Equity $ 65M Fairmount Funds Management,Venrock Healthcare Capital Partners Detail
Oct 30, 2018 Series B $ 80M Decheng Capital,Lilly Asia Ventures,etc. Detail
Jan 5, 2021 Series C $ 87M Deepfield,Eli Lilly,etc. Detail
Apr 4, 2018 Series A $ 30M Lilly Asia Ventures Detail
Feb 4, 2021 IPO $ 127.50M Detail